Leading Oral Health Care Company’s Product Research
Johnson & Johnson (J&J) is a global manufacturer of health care products as well as a provider of related services. The company operates predominantly through pharmaceuticals and medical devices and diagnostics. three divisions: consumer, J&J’s consumer division develops and markets products for baby and kids care, skin care, oral care, wound care, women’s health care, nutritional and over-the-counter pharmaceutical products. These products are distributed either through wholesalers or directly to independent and chain retail outlets. Major brands include: Aveeno (skin care products); Band-Aid (adhesive bandages); Carefree (panty liners); Clean & Clear (skin care products for teens); Johnson’s baby and adult lines of products; Motrin IB (ibuprofen products); Neutrogena (skin and hair care products); RoC (skin care products); Pepcid AC (acid controller), Merck Consumer Pharmaceuticals.; Rembrandt (oral care products); Splenda (sweetener); Stayfree (sanitary protection products); and Tylenol (acetaminophen products). In December 2006, J&J completed the acquisition of the consumer healthcare business of Pfizer comprising self-medications for oral care, upper-respiratory health, tobacco dependence, gastrointestinal health, skin care, eye care and hair growth products.
LEADING COMPANIES Familiar brands of the consumer healthcare business of Pfizer include Listerine (oral care products), Nicorette (smoking cessation treatments), and Sudafed (cold, flu and allergy products). The company’s pharmaceutical division produces and markets products in the following therapeutic areas: anti-fungal, anti-infective, cardiovascular, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, psychotropic (central nervous system), urology and virology. These products are professionals. distributed directly to retailers, wholesalers and health care Major brands include: Risperdal (risperidone) and Risperdal Consta (risperidone longacting injection), for treatment of the symptoms of schizophrenia; Procrit (epoetin alfa, sold outside the US as Eprex, a red blood cell production stimulant; Remicade (infliximab), to treat the symptoms of Crohn’s disease, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, chronic severe plaque psoriasis and rheumatoid arthritis; Topamax (topiramate), an anti-epileptic and migraine prevention treatment; Levaquin (levofloxacin) and Floxin (ofloxacin), both in the anti-infective field; Duragesic/Fentanyl Transdermal (fentanyl transdermal system, sold outside the US as Durogesic ), a treatment for chronic pain; Ortho Evra (norelgestromin/ethinyl estradiol transdermal system), a contraceptive patch and Ortho Tri-Cyclen LO (norgestimate/ethinyl estradiol), an oral contraceptive; Concerta (methylphenidate HCl) for attention deficit hyperactivity disorder; and Natrecor (nesiritide), for acutely decompensated congestive heart failure. J&J’s medical devices and diagnostics division includes products used principally in the professional fields of physicians, nurses, therapists, hospitals, diagnostic laboratories and clinics. Distribution to these markets is done both directly to health care professionals and indirectly through surgical supply dealers and other dealers. Product lines include surgical implants, instruments, needles and sutures; blood glucose monitoring systems; wound closure devices; endoscopic instruments; orthopedic products for joint repair and replacement and for correcting spinal deformities; contact lenses; clinical chemistry systems; medical devices, including cardiovascular monitoring and vascular access products; intravenous catheters and shunts; coronary and biliary stents.







